查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1764078

感染控制服装市场－全球产业规模、份额、趋势、机会和预测（按产品、最终用途、地区和竞争细分，2020-2030 年）

Infection Control Apparel Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End Use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024年，全球感染控制服饰市场规模为173.1亿美元，预计2030年将达222.9亿美元，复合年增长率为4.50%。新冠疫情在加速个人防护装备(PPE)需求方面发挥了关键作用，促使感染控制服装在医疗保健和非医疗保健领域得到广泛应用。由于感染预防仍然是全球关注的重点，预计这一势头将持续维持未来的市场成长。

市场概览
预测期 2026-2030
2024年市场规模 173.1亿美元
2030年市场规模 222.9亿美元
2025-2030 年复合年增长率 4.50%
成长最快的领域 隔离衣
最大的市场 北美洲

随着材料科学和纺织工程的进步，感染控制服正获得进一步发展，这些进步带来了透气性、耐液体性和抗菌保护等特性的服装，这些特性在高风险临床环境中尤其重要。然而，该市场仍面临许多障碍，尤其是製造和采购先进防护服的高成本，这可能会限制其在成本敏感地区的普及。

关键市场驱动因素

医疗保健产业的成长

主要市场挑战

先进材料成本上升

主要市场趋势

电子商务和数位分销平台的成长

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：COVID-19 对全球感染控制服饰市场的影响

第五章：全球感染控制服装市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 副产品（隔离服、化疗服、实验服、夹克）
    • 依最终用途（医院、门诊和外科中心、诊所、研究和诊断实验室、其他）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第六章：北美感染控制服饰市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第七章：欧洲感染控制服饰市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太感染控制服饰市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第九章：南美洲感染控制服饰市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章：中东与非洲感染控制服饰市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 合併与收购（如有）
  • 产品发布（如有）
  • 最新动态

第十三章：干扰：衝突、流行病与贸易壁垒

第 14 章：全球感染控制服装市场：SWOT 分析

第 15 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 16 章：竞争格局

  • 3M Company
  • DuPont de Nemours, Inc.
  • Cardinal Health, Inc.
  • Owens & Minor, Inc.
  • Medline Industries, Inc.
  • Lindstrom Group
  • Ansell Ltd
  • Delta Plus Group
  • Lakeland Industries Inc.
  • Protective Industrial Products, Inc.

第 17 章：策略建议

第18章调查会社について・免责事项

简介目录
Product Code: 5110

The Global Infection Control Apparel Market was valued at USD 17.31 billion in 2024 and is projected to reach USD 22.29 billion by 2030, growing at a CAGR of 4.50%. The COVID-19 pandemic played a pivotal role in accelerating the demand for personal protective equipment (PPE), leading to the widespread adoption of infection control apparel across healthcare and non-healthcare sectors. As infection prevention remains a key concern worldwide, this momentum is expected to sustain future market growth.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 17.31 Billion
Market Size 2030USD 22.29 Billion
CAGR 2025-20304.50%
Fastest Growing SegmentIsolation Gowns
Largest MarketNorth America

Infection control apparel is gaining further traction due to advancements in material science and textile engineering, which are yielding garments with features such as breathability, fluid resistance, and antimicrobial protection-particularly vital in high-risk clinical settings. However, the market continues to face obstacles, especially the high costs tied to manufacturing and procuring advanced protective garments, which can limit adoption in cost-sensitive regions.

Key Market Drivers

Growth in Healthcare Industry

The global healthcare industry's expansion is a primary force behind the rising demand for infection control apparel. With annual revenues exceeding USD 4 trillion, the industry comprises several major segments, including pharmaceuticals and biotechnology (USD 850 billion) and medical technology and diagnostics (USD 400 billion). As healthcare systems scale up across both developed and developing regions, the volume of clinical activities, surgical procedures, and patient admissions has also surged, leading to increased implementation of infection control measures.

The prevalence of healthcare-associated infections (HAIs) further underlines the critical role of protective apparel. On average, one in ten hospitalized patients contracts an HAI, with rates significantly higher in low- and middle-income countries. Vulnerable populations, such as ICU patients, face even greater risks. In Europe, the overall burden of the six most common HAIs surpasses that of 32 other major infectious diseases combined, reinforcing the necessity for effective infection prevention strategies, including the use of high-quality protective clothing.

Key Market Challenges

Rising Cost of Advanced Materials

The rising cost of high-performance materials used in manufacturing infection control apparel is a significant hurdle in market growth. Products like surgical gowns, gloves, masks, and coveralls now incorporate specialized materials with features such as antimicrobial properties, enhanced fluid resistance, and breathability. These sophisticated fabrics-including multi-layer synthetics and coated nonwovens-are notably more expensive than traditional materials.

With global safety standards becoming more rigorous, manufacturers must invest in materials that meet stringent performance and regulatory criteria. This increase in production cost elevates end-product pricing, posing financial challenges for healthcare systems-especially in regions where budget constraints impact purchasing decisions.

Key Market Trends

Growth of E-Commerce and Digital Distribution Platforms

The expansion of e-commerce and digital distribution platforms is emerging as a transformative trend in the global infection control apparel market. As demand for PPE and infection control garments grows across healthcare and industrial sectors, manufacturers and suppliers are increasingly utilizing digital channels to reach broader customer bases and streamline procurement.

Notably, initiatives such as Toray Industries' collaboration with the Guinean government underscore the growing role of digital and global outreach in supporting infectious disease prevention. Online portals now allow hospitals and healthcare professionals to place orders more efficiently, track inventory in real-time, and access regulatory documentation-offering significant advantages over traditional supply chains.

Key Market Players

  • 3M Company
  • DuPont de Nemours, Inc.
  • Cardinal Health, Inc.
  • Owens & Minor, Inc.
  • Medline Industries, Inc.
  • Lindstrom Group
  • Ansell Ltd
  • Delta Plus Group
  • Lakeland Industries Inc.
  • Protective Industrial Products, Inc.

Report Scope

In this report, the Global Infection Control Apparel Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Infection Control Apparel Market, By Product:

  • Isolation Gowns
  • Chemotherapy Gowns
  • Lab Coats
  • Jackets

Infection Control Apparel Market, By End Use:

  • Hospitals
  • Ambulatory & Surgical Centers
  • Clinics
  • Research & Diagnostic Labs
  • Others

Infection Control Apparel Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Infection Control Apparel Market.

Available Customizations

Global Infection Control Apparel Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Infection Control Apparel Market

5. Global Infection Control Apparel Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Isolation Gowns, Chemotherapy Gowns, Lab Coats, Jackets)
    • 5.2.2. By End Use (Hospitals, Ambulatory & Surgical Centers, Clinics, Research & Diagnostic Labs, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Infection Control Apparel Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Infection Control Apparel Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Infection Control Apparel Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Infection Control Apparel Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End Use

7. Europe Infection Control Apparel Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Infection Control Apparel Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Infection Control Apparel Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Infection Control Apparel Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Infection Control Apparel Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Infection Control Apparel Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By End Use

8. Asia Pacific Infection Control Apparel Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Infection Control Apparel Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Infection Control Apparel Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Infection Control Apparel Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Infection Control Apparel Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Infection Control Apparel Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By End Use

9. South America Infection Control Apparel Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Infection Control Apparel Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Infection Control Apparel Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Infection Control Apparel Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Infection Control Apparel Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Infection Control Apparel Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Infection Control Apparel Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Infection Control Apparel Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Infection Control Apparel Market: SWOT Analysis

15. Porters Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. 3M Company
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. DuPont de Nemours, Inc.
  • 16.3. Cardinal Health, Inc.
  • 16.4. Owens & Minor, Inc.
  • 16.5. Medline Industries, Inc.
  • 16.6. Lindstrom Group
  • 16.7. Ansell Ltd
  • 16.8. Delta Plus Group
  • 16.9. Lakeland Industries Inc.
  • 16.10. Protective Industrial Products, Inc.

17. Strategic Recommendations

18. About Us & Disclaimer